相关实验视频

Updated: Jan 17, 2026

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

治疗听力损失:从耳植入到基因疗法

Fan-Gang Zeng¹, Jieyu Qi^2,3,4, Chen-Chi Wu^5,6

¹Center for Hearing Research, Departments of Anatomy and Neurobiology, Biomedical Engineering, Cognitive Sciences, Otolaryngology-Head and Neck Surgery, University of California Irvine, Irvine, CA, 92697, USA.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

|September 23, 2025

概括

基因治疗为OTOF基因突变提供了自然听力恢复,显示出显著的改善. 需要进一步的研究来了解变异性,并将其与先天性聋的耳植入器进行比较.

科学领域:

耳鼻喉科耳鼻喉科耳鼻喉科
遗传学遗传学是一个
再生医学是一种再生医学.

背景情况:

基因疗法正在成为遗传性听力损失的新疗法.
通过基因疗法恢复自然听力不同于通过耳植入器提供的人工听力.
在OTOF基因的突变导致一种形式的先天性聋 (DFNB9).

研究的目的:

审查OTOF基因突变的基因治疗现状.
识别知识缺口和听力损失基因治疗的未来方向.
为了比较基因治疗与耳植入器的疗效和安全性.

主要方法:

对接受基因治疗的DFNB9患者发表的试验数据的分析.
对不良事件和听力改善的审查.
确定未来研究的领域,包括时间处理和比较疗效.

主要成果:

在DFNB9患者中,基因疗法显示出大量 (平均改善52.4dB),快速和稳定的听力恢复.
副作用主要是轻微的 (244级I/II),严重的事件很少 (2级III),没有严重的不良事件.
观察到结果的显著个体变化,从正常听力到严重听力损失.

结论:

基因疗法是对先天性聋的单基因形式,特别是OTOF基因突变的有前途的治疗方法.
需要进一步的研究来解决个体结果的变化,时间处理和与耳植入器的直接比较.
传递和基因编辑技术的进步有望提高对听力损失的基因治疗的安全性和有效性.

关键词:

DFNB9 DFNB9 在线观看一个人的死亡.听觉神经病变是一种听觉神经病变.耳植入式耳道植入器基因治疗的基因疗法遗传性听力损失是一种遗传性听力损失.

更多相关视频

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Canalostomy As a Surgical Approach to Local Drug Delivery into the Inner Ears of Adult and Neonatal Mice

Published on: May 25, 2018

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...